However, most patients with persistent inflammatory bowel disease or gastrointestinal symptoms do not have IgAN, suggesting that IgA produced in the intestinal tract can migrate into the blood without causing secondary IgAN. This evidence concerns the gene CD79A and inflammatory bowel disease.